|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||1.50 / 5.00|
Struggling Mass. biotech firm Epix Pharmaceuticals explores strategic options, including sale
Epix Pharmaceuticals may file for bankruptcy protection; offers cash and stock for debt
It may be best to wait for data from two clinical studies on Alzheimer's drug PRX-03140 before making any predictions about its prospects.
A wild day leaves major averages slightly higher. James Bianco opines on the credit crunch, and Dan Fitzpatrick on the search for Santa.
Adobe rises on earnings; iRobot shares salute Army contract.